ACERX
Price
$10.35
Change
-$0.08 (-0.77%)
Updated
Jun 13 closing price
Net Assets
12.21B
RLBGX
Price
$35.65
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

ACERX vs RLBGX

Header iconACERX vs RLBGX Comparison
Open Charts ACERX vs RLBGXBanner chart's image
Invesco Equity and Income C
Price$10.35
Change-$0.08 (-0.77%)
VolumeN/A
Net Assets12.21B
American Funds American Balanced R6
Price$35.65
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets244.39B
ACERX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ACERX vs. RLBGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACERX is a StrongBuy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 244B vs. ACERX (12.2B). RLBGX pays higher dividends than ACERX: RLBGX (2.23) vs ACERX (1.21). ACERX was incepted earlier than RLBGX: ACERX (32 years) vs RLBGX (16 years). ACERX (1.52) is less costly to investors than RLBGX (0.25). ACERX is a more actively managed with annual turnover of: 139.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than ACERX: RLBGX (250) vs ACERX (1000). RLBGX annual gain was more profitable for investors over the last year : 5.63 vs. ACERX (2.12). RLBGX return over 5 years is better than : 40.35 vs. ACERX (18.38).
ACERXRLBGXACERX / RLBGX
Total Expense Ratio1.510.25604%
Annual Report Gross Expense Ratio1.520.25608%
Fund Existence32 years16 years-
Gain YTD2.1524.59247%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets12.2B244B5%
Annual Yield % from dividends1.212.2354%
Returns for 1 year2.125.6338%
Returns for 3 years10.5033.7831%
Returns for 5 years18.3840.3546%
Returns for 10 years9.0760.8715%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC1.680.06
+3.70%
C4 Therapeutics
PNTG27.67-0.07
-0.25%
Pennant Group (The)
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
GSAT21.95-0.24
-1.08%
Globalstar Inc
KTTA0.79-0.04
-5.21%
Pasithea Therapeutics Corp